Submissions from 2022
An Atypical Case of Extreme Polypharmacy, Michael A. Veronin
Submissions from 2021
Assessing potentiation of the (α4)3(β2)2 nicotinic acetylcholine receptor by the allosteric agonist CMPI, Farah Deba, Kemburli Munoz, Eloisa Peredia, Gustav Akk, and Ayman K. Hamouda
Submissions from 2020
Examining the Effects of (α4)3(β2)2 Nicotinic Acetylcholine Receptor-Selective Positive Allosteric Modulator on Acute Thermal Nociception in Rats, Farah Deba, Kara Ramos, Matthew Vannoy, Kemburli Munoz, Lois S. Akinola, M. Imad Damaj, and Ayman K. Hamouda
Submissions from 2019
Development of a Unique Student Pharmacist Internship in a Primary Care Provider System, Norman E. Fenn III, Natalie R. Gadbois, Gwen J. Seamon, Shannon L. Castek, and Kimberly S. Plake
Submissions from 2015
Pharmacologic Activities of 3’-Hydroxypterostilbene: Cytotoxic, Anti- Oxidant, Anti-Adipogenic, Anti-Inflammatory, Histone Deacetylase and Sirtuin 1 Inhibitory Activity, Jody K. Takemoto, Connie M. Remsberg, and Neal M. Davies